[Third generation calcium antagonist lercanidipine: the evidence base for clinical decision]

Kardiologiia. 2014;54(2):43-6. doi: 10.18565/cardio.2014.2.43-46.
[Article in Russian]
No abstract available

Publication types

  • Review

MeSH terms

  • Calcium Channel Blockers / administration & dosage
  • Calcium Channel Blockers / therapeutic use*
  • Dihydropyridines / administration & dosage
  • Dihydropyridines / therapeutic use*
  • Evidence-Based Medicine
  • Humans
  • Hypertension / drug therapy*

Substances

  • Calcium Channel Blockers
  • Dihydropyridines
  • lercanidipine